10
Shared Docs
10
Same-Page
10 / 10
Mentions
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atriity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atriity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atriity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
DARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In this Access Fund will be subject to fees, expenses and pericomance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Access expanses and will experience lower returns than investors committing directly to the Underlying Find as
ances ard otte *N5anSce; tnat Wan reoitn serums. tr, ..8110i$ trodd nitre the &wired atriity and ....nodose:: to accept the isk chnrectenstict of the Accat; Funds investments. Potential confIcts of interne :nay anse between the :Serval Platelet end the Un=to Partnea lo ch conflicts ol intern: are tennve
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atiiiity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atiiiity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; teat tr, ..8110i$ trodd nitre da &wired atiiiity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
DARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In this Access Fund will be subject to fees, expenses and pericomance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Access expanses and will experience lower returns than investors committing directly to the Underlying Find as
ances ard otte *N5anSce; tnat Wan reoitn serums. tr, ..8110i$ trodd nitre the &wired atriity and ....nodose:: to accept the isk chnrectenstict of the Accat; Funds investments. Potential confIcts of interne :nay anse between the :Serval Platelet end the Un=to Partnea lo ch conflicts ol intern: are tennve
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atriity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
NDARY OPPOR FUNI I IES IV (U.S.). LP END NOTES Note, Investors In the Access Fund will to subject to fees, expenses and performance compensation of the Underlying Fund In ackellors to the Access Fund Fee and Ames expenses and will experience lower returns than investors committing directly to the Underlying Find as a
onownwinco iglocancnis ana Othei *N5anSce; tnat tr, ..8110i$ trodd nitre da &wired atriity and ....nodose:: to accept tnt isk chnrectonstics of the Accat; Fund's investments. Potential confIcts of interest may arise between the Genial Platelet end the Lientsd Partner,. lo ch conflicts ol intern: are d
Entities connected to both the Underlying Fund In and Accat
Sicce
PERSONMen 45 million
ORGANIZATIONVigtedying Ford
PERSONFoss Performance
ORGANIZATIONAccess Funes Private Placement
ORGANIZATIONthe Acorn Fund
ORGANIZATIONACCess
ORGANIZATIONThe Accts.
ORGANIZATION
Crick
PERSONAbress
ORGANIZATION
Samantha Power
PERSONInvestment
ORGANIZATIONSeidman
PERSONCeiconstron
ORGANIZATIONCroligations
ORGANIZATIONthe Untenerdig Fund
ORGANIZATIONGlendaser Capital
ORGANIZATIONAccess Fuses
ORGANIZATIONthe Acceao Ford Tarns
ORGANIZATIONCoeditors
ORGANIZATION